LabStyle Innovations Announces Uplisting to NASDAQ and Capital Raise of $8.5 Million |
March 05, 2016 | March 2016 Bond Updates |
CAESAREA, Israel, March 4, 2016 /PRNewswire/ --
LabStyle Innovations Corp. (DRIO), developer of the Dario™ Diabetes Management Solution, today announced approval to list its common stock and warrants on the NASDAQ Capital Market effective March 4, 2016, and will trade under the... |
View more at: http://www.prnewswire.com/news-releases/labstyle-innovations-announces-uplisting-to-nasdaq-and-capital-raise-of-85-million-571033701.html |
Related News |
|